1. The impact of prior long-term versus short-term statin use on the mortality of bacteraemic patients
- Author
-
W, Nseir, J, Mograbi, J, Khateeb, O, Abu-Elheja, J, Bishara, B, Jihad, and N, Assy
- Subjects
Adult ,Male ,Microbiology (medical) ,medicine.medical_specialty ,Time Factors ,Bacteremia ,Internal medicine ,Humans ,Medicine ,Hospital Mortality ,cardiovascular diseases ,Israel ,Aged ,Retrospective Studies ,Aged, 80 and over ,Lipid Regulating Agents ,business.industry ,Proportional hazards model ,Incidence ,Mortality rate ,Hazard ratio ,Confounding ,nutritional and metabolic diseases ,Retrospective cohort study ,General Medicine ,Emergency department ,Middle Aged ,Statin treatment ,Survival Analysis ,Confidence interval ,Surgery ,Treatment Outcome ,Infectious Diseases ,Multivariate Analysis ,Female ,Hydroxymethylglutaryl-CoA Reductase Inhibitors ,business - Abstract
The aim of this investigation was to assess the effect of prior statin use on the 30-day in-hospital mortality among bacteraemic patients and to determine the impact of long-term versus short-term statin use on the mortality of bacteraemic patients. A retrospective study of 342 bacteraemic patients who presented to the emergency department (ED) within a period of 7 years was undertaken. Twenty-three patients did not meet the inclusion criteria. The remaining 319 patients were divided into three groups according to statin use and duration of therapy prior to the bacteraemic episode: group 1 (n = 123) had long-term statin use ≥12 weeks, group 2 (n = 35) had short-term statin use
- Published
- 2011
- Full Text
- View/download PDF